Stockreport

Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial

Clearmind Medicine Inc.  (CMND) 
PDF Vancouver, Canada, March 13, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"), a clinical- stage biotec [Read more]